At Olifant, we are passionate about finding solutions that improve the lives of your patients. We prioritize responsible and ethical sourcing for our biological products so that they meet the highest standards of quality and safety.
With Olifant, you can trust your patients are achieving optimal results.
Integrity, accountability, performance, and gratitude – for customers and one another – are the foundation of our organization. We carry these values throughout every part of our business and trust you will do the same when working with us.
PurePRP® is a proprietary form of autologous platelet rich plasma developed by our supplier. It contains a complex composition of cellular components derived from your blood biologic that can be used to treat and repair a host of injuries and conditions. It is the cornerstone of the consortium of regenerative therapies used in modern medicine and rapidly becoming a standard of care. It’s chosen over surgery for many conditions, ranging from degenerative joint disease, to tendon and ligament injuries because its regenerative power is shown to play an adjunctive role in clinical outcomes.
Designed to fill bony voids or gaps, providing a scaffold for bone ingrowth with the patient’s own bone. A ready-to-use alternative to autograft for bone regeneration, cancellous crushed bone chips can be used to augment autologous cancellous or corticocancellous grafts and used in craniofacial surgery, spinal fusion, hand and foot surgery, joint reconstruction and fracture repair. Easy to use Quick preparation Room temperature storage
A slim, pliable demineralized cortical allograft bone sheet can be shaped using scissors or a scalpel when hydrated. It withstands sutures and can be tacked into place. Due to its flexible nature and inherent body can easily be inserted into a periosteal pouch without total refection and maintain bone contour. It is verified to be osteoinductive post-sterilization using in-vivo testing to demonstrate, histologically, the five elements of bone formation: chondrocytes, osteocytes, bone marrow, cartilage, and new bone formation.
Transform the way you practice and achieve better patient outcomes with Olifant Biologics. Contact us today to learn more about our PRP kits and how we can support you.
Providing solutions for acute and chronic care challenges while creating exceptional patient & provider experiences.
MKT-001 rev B
900 Isom Rd. Ste, 250
San Antonio, TX 78216
P. 210-960-9035
F. 210-960-3575
customerservice@olifantmedical.com
© Copyright All Rights Reserved 2023 Olifant Medical™ | Powered by Tribu Digital Marketing, Advertising, & Design
GENERAL MANAGER, COO
With over 30 years of experience in management and leadership, Jeff currently holds the position of General Manager and Chief Operating Officer at Olifant Medical. He oversees the company’s day-to-day operations, including accounting, quality management, inventory, contract negotiation, project management, and marketing. His leadership has led to the development of cutting-edge medical technologies, such as stylet technologies, ETT securement devices, an ETI protective barrier enclosure, and an advanced nasopharyngeal airway.
Before his current role, Jeff was crucial in bringing eight product families to the US market, including K124022 Staple, Fixation, Bone; K133321 Intervertebral Fusion Device with Bone Graft, Cervical; and K141993 Appliance, Fixation, Spinal Intervertebral Body. He authored, validated, and managed quality management systems, ensuring successful FDA inspections and gaining ISO 13485 certification. He is a certified quality auditor in internal and external audits and is skilled in Medical Device Risk Management and Root Cause Analysis.
Jeff has an impressive academic background, including a Bachelor of Science in Chemistry and Biotechnology from West Texas A&M University and an MBA from Western Governors University. He was pursuing a Master of Jurisprudence at Texas A&M University and obtained PMP Certification in 2019.
Throughout his career, Jeff has worked on diverse projects ranging from Characterizing Organic Cation Pathways Across Cell Membranes to Natural Gas to Liquid Gasoline Method Determination. He has extensive experience in rapid antigen detection and identification using Pyrosequencing technology and designing/delivering cancer therapy pharmaceuticals on the nanoscale.
Education
Western Governors University, MBA, 2014; West Texas A & M University, BS Chemistry, BS Biotechnology, 2007, Texas A & M University, M. Jur., in-progress; PMP Certification, 2019
MKT-001 Rev B
Over 23 years of experience in academic, military, and private practice medicine. Professor of Anesthesiology and Surgery. Active practice in anesthesiology and critical care medicine. Dr. Venticinque has directed numerous clinical and academic programs, including program director of critical care medicine fellowships and consortium director of a multidisciplinary, multi-hospital critical care training collaborative. He has authored over 45 book chapters, journal articles, and scientific abstracts and has coordinated numerous national and international workshops. Research interests include airway management, echocardiography, the anesthesia workstation, clinical pathways, and medical device development. Board Examiner, American Board of Anesthesiology. 20 years of active-duty military service. In the U.S. Navy he served as an Aircrewman on reconnaissance aircraft. In the U.S Air Force he served as an anesthesiologist and Critical Care Air Transport Team (CCATT) leader and has transported patients all over the world on both strategic and tactical missions. He also served as an anesthesiologist within austere military settings and has authored manuscripts pertaining to austere medical care. Co-founder, Olifant Medical.
Education
Fellowship in Anesthesiology Critical Care Medicine, San Antonio Uniformed Services Health Education Consortium, San Antonio, TX, 1999; Residency in Anesthesiology Wilford Hall Medical Center, Lackland Air Force Base, TX, 1998; Internship in General Surgery, Wilford Hall Medical Center, Lackland Air Force Base, TX, 1995; MD, University of Florida College of Medicine, Gainesville, FL, 1994; BS, Biology University of West Florida, Pensacola, FL, 1990.
MKT-001 Rev B
TERRITORY SALES MANAGER
Sydnie Monique Caradec is a Territory Sales Manager for Olifant Biologics, a leading biotechnology company specializing in innovative treatments for musculoskeletal disorders. As a registered nurse with experience in orthopedics, Sydnie is uniquely qualified to promote Olifant Biologics products to healthcare professionals.
Sydnie’s career in healthcare began when she earned her degree in nursing from Austin Community College in 2020. She gained valuable experience in orthopedics, working with patients with musculoskeletal disorders, injuries, and surgeries. Her experience as a nurse gave her a deep understanding of the importance of quality healthcare and its impact on people’s lives.
After several years of experience in nursing, Sydnie found a new passion for medical sales. She joined Olifant Biologics, now serving as a Territory Sales Manager. In her role, she works with healthcare professionals to promote Olifant’s innovative products and educate them on the benefits of these treatments.
Sydnie’s experience as a registered nurse and her knowledge of musculoskeletal disorders give her a unique perspective when working with healthcare professionals. She is passionate about improving patient outcomes and providing innovative solutions for people suffering from musculoskeletal conditions.
When Sydnie is not working, she enjoys spending time with her dog, Lucky. Lucky is a beloved member of her family, and they enjoy exploring the beautiful scenery around New Braunfels together. Sydnie also enjoys hiking, biking, and kayaking and is an active local community member.